Fermenta Biotech Limited (NSE:FERMENTA)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Bulk Drugs/chemicals	5.15B	4.00B	2.59B	2.80B	3.85B
Property	95.13M	544.02M	737.42M	630.34M	166.00M
Unallocated	235.80M	264.06M	145.20M	159.22M	-
Inter-Segment	-	-	-	-	-1.80M
Total	5.48B	4.81B	3.47B	3.59B	4.02B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	2.15B	2.19B	1.82B	1.67B	1.45B
Europe	1.62B	1.15B	571.19M	681.99M	1.03B
USA	731.22M	725.60M	372.88M	418.78M	493.65M
Others Countries	976.82M	752.53M	707.45M	813.97M	1.08B
Total	5.48B	4.81B	3.47B	3.59B	4.07B

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error